39,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
  • Broschiertes Buch

The practice of pathology is currently undergoing significant change in large part due to advances in the analysis of DNA, RNA, and proteins in tissues. The analysis of DNA, RNA, and proteins, obtained from diagnostic specimens, is currently revolutionizing the practice of surgical pathology and heralds a new era of diagnostic and prognostic tests that will greatly influence our day-to-day clinical decision-making. The diagnosis of cancer and many other diseases is fundamentally based on the microscopic study of cells and tissues and remains the standard by which all other diagnostic tests are…mehr

Produktbeschreibung
The practice of pathology is currently undergoing significant change in large part due to advances in the analysis of DNA, RNA, and proteins in tissues. The analysis of DNA, RNA, and proteins, obtained from diagnostic specimens, is currently revolutionizing the practice of surgical pathology and heralds a new era of diagnostic and prognostic tests that will greatly influence our day-to-day clinical decision-making. The diagnosis of cancer and many other diseases is fundamentally based on the microscopic study of cells and tissues and remains the standard by which all other diagnostic tests are measured. Nevertheless, the era when the pathologist relies entirely on the examination of tissue sections stained by histochemical methods is gradually being replaced by a time with advanced immunologic and molecular techniques that augment disease diagnosis and classification. The aim of this book is to enumerate the advanced molecular diagnostic methods and to elicit their effectiveness by reviewing the available literature.
Autorenporträt
Il Dr. Mamidi Sankar ha conseguito il BDS presso il GITAM Dental College and Hospital nel 2018 e il MDS nel Dipartimento di Patologia Orale e Microbiologia e Odontologia Forense nel 2022 presso la Dr. N.T.R. University of Health Sciences. È interessato a individuare il più precocemente possibile i tumori maligni della testa e del collo utilizzando tecnologie avanzate.